<<

Genome-wide and targeted analysis of DNA methylation patterns

Devin Absher, Ph.D. HudsonAlpha Institute for Biotechnology Genetic Association Studies

oBipolar Disorder o Pritzker Consortium oCardiovascular Disease o Stanford, HudsonAlpha, Kaiser Clinics oAutoimmune Diseases o Rheumatoid Arthritis (Lou Bridges, UAB) o Systemic Lupus Erythematosus (Bob Kimberly, UAB)

Genetic Association Studies

oADVANCE: Multi-ethnic study of cardiovascular disease o Two-stage design: 1500 cases / 1500 controls; 7000 cases / 7000 controls o Meta-analysis of other : smoking, BMI, height, weight, MetS oCARDIOGRAM: Meta-analysis of CAD o >87,000 individuals Genetic Association Studies Genetic Association Studies

oCardiovascular Disease o 25 loci o <5% of genetic risk explained oType 2 Diabetes o 16 loci o <10% of genetic risk explaned

Why ?

oHeritability (?) oConfounding of genetic effects oMolecular readout of environmental variance

Complexities and Questions

oTissue specific epigenetic marks o How much complexity can we handle? oGenetics of epigenetics o What are the genetic influences on epigenetics? o How diverse are human populations? oAging o How does the epigenome change with age? oEnvironment o Smoking, Diet oDiseases o Cause or effect? Aging and DNA Methylation

o4 human tissues (kidney, brain, blood, muscle); 50-100 each

oBroad age range

oIllumina Methylation27 microarrays (>27,000 CpGs)

oLinear Regression Model

%DNAm = b1Age + b2Gender + e Aging and DNA Methylation Aging and DNA Methylation

Kidney Brain Blood

1499 614 1172 Significant CpGs (FDR<0.01) Aging and DNA Methylation

Brain

269

127 55

110

881 197 638

Kidney Blood Process GO Terms

Cell development 22 Regulation of 21 differentiation 20 Developmental process 19 Multicellular organismal process18 Multicellular organismal dev 17

Embryonic limb development16

Neurogenesis 15 kidney Limb morphogenesis 14 13 blood Anatomical struct morphogenesis12 brain Organ morphogenesis 11

Neuron differentiation 10

Limb development 9

Embryonic morphogenesis 8

Nervous system development7

Neuron generation 6

Pattern specification 5

Cell fate commitment 4

Anatomical struct development3

Organ development 2

System development 1

0 2 4 6 8 10 12 14 -log (Corrected P-value) Targeted Bisulfite Sequencing

Multiple , small regions Targeted Bisulfite Sequencing

96 1-2kb PCR Products (96 genes)

T7

T7

T7

T7

T7 Bisulfite

GAIIx Targeted Bisulfite Sequencing

o 24 sample multiplexing in each 36bp PE lane

o >150X mean coverage per sample

o 60-70% reads on target Targeted Bisulfite Sequencing

10 oldest v. 11 youngest kidney tissues

NEUROD1 SOX14

2 2

. .

0 0

1 1

. .

n n

0 0

o o

i i

t t

a a

l l

y y

h h

t t

e e

0 0

. .

m m

0 0

% %

a a

t t

l l

e e

1 1

. .

D D

0 0

− −

2 2

. .

0 0

− −

182547000 182547500 182548000 182548500 137482500 137483000 137483500 137484000 Targeted Bisulfite Sequencing

10 oldest v. 11 youngest kidney tissues

ELOVL3

2

.

0

1

.

n

0

o

i

t

a

l

y

h

t

e

0

.

m

0

%

a

t

l

e

1

.

D

0

2

.

0 −

103985600 103985800 103986000 103986200 103986400 103986600 Targeted Bisulfite Sequencing

Large, contiguous regions Cardiovascular Disease Cardiovascular Disease Cardiovascular Disease

ANRIL 9p21 CDKN2A CDKN2B Cardiovascular Disease

ANRIL 9p21 CDKN2A CDKN2B Methylation 450

o >480,000 CpGs

o >95% of RefSeq genes

o CpG Island, bodies, promoters, 3’ ends, predicted regulatory elements 4 Brain Samples – Methyl450 and RRBS

Methyl450 RRBS Pearson Correlation Coeff.

0.935 0.940 0.945 0.950 0.955 0.960 0.965 All CpGs

MspI

Sites

NonMspI 42,595 RRBS

Same Strand CpGs v . Methyl450.

in Common

Opp. Strand

Inf. Inf. I

Inf. Inf. II

Controls – Unmethylated, Hemi-methylated, Methylated 0 2 Inf. I

Inf. II

5

1

y

c

n

e

0

u

1

q

e

r

F

5 0

0.0 0.2 0.4 0.6 0.8 1.0

Beta Methylation 450

o Lupus

o Triglycerides / Diet

o Cardiovascular Disease

o Bipolar Disorder

Twins – Discordant, Autoimmune

RA JRA RA JDM JDM

JDM SLE SLE SLE SLE Acknowledgments

Absher Lab Collaborators Kenny Day Jan Dumanski, Uppsala Lindsay Jones Fred Miller, NIH Kimberly Hobbs Uli Broeckel, MCW Krista Thibeault Andy West, UAB Kevin Roberts Donna Arnett, UAB Matt Lewis Jim Brooks, Stanford Tom Quertermous, Stanford